These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3827787

  • 1. Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration.
    Kohl RL.
    Aviat Space Environ Med; 1987 Feb; 58(2):125-31. PubMed ID: 3827787
    [Abstract] [Full Text] [Related]

  • 2. Hormonal responses of metoclopramide-treated subjects experiencing nausea or emesis during parabolic flight.
    Kohl RL.
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A266-9. PubMed ID: 2823788
    [Abstract] [Full Text] [Related]

  • 3. The effective intensity of Coriolis, cross-coupling stimulation is gravitoinertial force dependent: implications for space motion sickness.
    Lackner JR, Graybiel A.
    Aviat Space Environ Med; 1986 Mar; 57(3):229-35. PubMed ID: 3485968
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
    Mystakidou K, Befon S, Liossi C, Vlachos L.
    Cancer; 1998 Sep 15; 83(6):1214-23. PubMed ID: 9740088
    [Abstract] [Full Text] [Related]

  • 5. What you thought you knew about motion sickness isn't necessarily so.
    Cowings PS, Malmstrom FV.
    Flying Saf; 1984 Feb 15; 40(2):12-7. PubMed ID: 11540877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Hardy J, Daly S, McQuade B, Albertsson M, Chimontsi-Kypriou V, Stathopoulos P, Curtis P.
    Support Care Cancer; 2002 Apr 15; 10(3):231-6. PubMed ID: 11904788
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
    Wood CD, Stewart JJ, Wood MJ, Manno JE, Manno BR, Mims ME.
    Aviat Space Environ Med; 1990 Feb 15; 61(2):157-61. PubMed ID: 2178599
    [Abstract] [Full Text] [Related]

  • 10. [Model of motion sickness in dogs for assessing the effectiveness of pharmacological substances].
    Radkevich LA.
    Kosm Biol Aviakosm Med; 1977 Feb 15; 11(6):50-3. PubMed ID: 22775
    [Abstract] [Full Text] [Related]

  • 11. Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.
    Chiara S, Scarsi P, Campora E, Bruzzi P, Tatarek R, Rosso R.
    Chemioterapia; 1984 Oct 15; 3(5):333-6. PubMed ID: 6398127
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-dose metoclopramide in the treatment of cis-platinum induced emesis. A dose-finding study.
    Tropé C, Danneskiold-Samsøe P, Hauksson A.
    Neoplasma; 1985 Oct 15; 32(4):507-12. PubMed ID: 4047261
    [Abstract] [Full Text] [Related]

  • 14. Mechanics of Coriolis stimulus and inducing factors of motion sickness.
    Isu N, Shimizu T, Sugata K.
    Biol Sci Space; 2001 Dec 15; 15(4):414-9. PubMed ID: 12101369
    [Abstract] [Full Text] [Related]

  • 15. Gastric arrhythmia and nausea of motion sickness induced in healthy Japanese subjects viewing an optokinetic rotating drum.
    Imai K, Kitakoji H, Sakita M.
    J Physiol Sci; 2006 Oct 15; 56(5):341-5. PubMed ID: 17002813
    [Abstract] [Full Text] [Related]

  • 16. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct 15; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes of skin potential level and of skin resistance level corresponding to lasting motion discomfort.
    Isu N, Koo J, Takahashi N.
    Aviat Space Environ Med; 1987 Feb 15; 58(2):136-42. PubMed ID: 3827789
    [Abstract] [Full Text] [Related]

  • 20. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
    Colls BM, Ferry DG, Gray AJ, Harvey VJ, McQueen EG.
    N Z Med J; 1980 Jun 25; 91(662):449-51. PubMed ID: 6250106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.